Use of the Loop Open-Source Automated Insulin Delivery System in Children with Type 1 Diabetes: Six-Month Results from a Single Center

Key Points

• Improved glycemic outcomes without increased risk of hypoglycemia or diabetic ketoacidosis are observed.
• After six months of use, the Loop system significantly enhanced diabetes management in pediatric populations.
• The system's effectiveness indicates a promising alternative to traditional insulin therapies, enhancing daily life for children with type 1 diabetes.
• Future studies are warranted to ensure findings are replicated across larger populations and longer timeframes.